Vaccizone has selected Exothera S.A. to fast-track process development of its SARS-CoV-2 vaccine for European clinical trials.

Mogrify Limited and Astellas Pharma Inc. have announced that they have executed a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss.

Lonza today announced that its Board of Directors has appointed Maria Soler Nunez as the new Head, Group Operations.

BUCHI Labortechnik has launched the Mini Spray Dryer S-300, a new generation of spray drying systems.

Lucius Partners, LLC has reported that its portfolio company, Voltron Therapeutics, Inc., had announced the initiation of a preclinical study of its novel vaccine candidate VTX-067 in an immune-oncology model.

On Friday 1 July, Health Data Research UK launches its Health Data Science Black Internship Programme for 2022 helping to tackle the underrepresentation of Black people within science, technology, engineering, and mathematics careers. 

Peli BioThermal recently concluded its InnovationShare webinar series. Launched in March 2021, InnovationShare was designed to fill the in-person learning gap during the height of the COVID-19 pandemic.

Lonza has launched the PyroCell® Monocyte Activation Test - Human Serum System (PyroCell® MAT HS System), which uses human serum instead of fetal bovine serum.

ProteoGenix, Aseem Healthcare and Trident Biopharm Solutions are pleased to announce the development of a new antibody cocktail effective against major variants of SARS-CoV-2.

Spirea Limited has announced that it has secured funding of £2.4 million with investments from high-profile UK and US investors.